Synthesis and evaluation of new thiourea derivatives as antitumor and antiangiogenic agents

被引：28
作者：
Bai, Wenjing [1 ,2 ]
Ji, Jianxin [1 ]
Huang, Qiang [4 ]
Wei, Wei [3 ]
机构：
[1] Chinese Acad Sci, Chengdu Inst Biol, Chengdu 610041, Peoples R China
[2] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[3] Chinese Acad Sci, Northwest Inst Plateau Biol, Qinghai Prov Key Lab Tibetan Med Res, Xining 810008, Qinghai, Peoples R China
[4] Zunyi Med Univ, Sch Pharm, Dept Clin Pharm, Zunyi 563000, Guizhou, Peoples R China
来源：
TETRAHEDRON LETTERS | 2020年 / 61卷 / 40期
关键词：
Thiourea derivatives; Antitumor; Antiangiogenesis; RTK inhibitors; MULTIKINASE INHIBITOR; ANGIOGENESIS; SORAFENIB; GROWTH; DESIGN; DISCOVERY; CARCINOMA; PATHWAYS; INVASION; VEGF;
D O I：
10.1016/j.tetlet.2020.152366
中图分类号：
O62 [有机化学];
学科分类号：
070303 ; 081704 ;
摘要：
A series of novel thiourea derivatives were synthesized and evaluated by biological activities. Among them, compound 10e containing 3,5-bis(trifluoromethyl)phenyl moiety (R-1) at the terminal thiourea and phenylamino (R-2) at the terminal acyl position showed the best cytotoxic activities against seven cancer cell lines (NCI-H460, Colo-205, HCT116, MDA-MB-231, MCF-7, HepG2, PLC/PRF/5) and HUVECs. Moreover, compound 10e moderately inhibited various RTKs such as VEGFR2, VEGFR3, and PDGFR beta. Notably, 10e exhibited much better inhibitory effect of tumor formation and antiangiogenic activities than Sorafenib and Regorafenib at the same concentration. Further docking studies suggested that 10e could serve as potential candidate for cancer therapy. (C) 2020 Elsevier Ltd. All rights reserved.
引用
收藏
页数：7
相关论文
共 33 条
[1]   Thiourea derivatives incorporating a hippuric acid moiety: Synthesis and evaluation of antibacterial and antifungal activities [J].
Abbas, Samir Y. ;
El-Sharief, Marwa A. M. Sh. ;
Basyouni, Wahid M. ;
Fakhr, Issa M. I. ;
El-Gammal, Eman W. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 64 :111-120
[2]   Lenvatinib: A Review in Hepatocellular Carcinoma [J].
Al-Salama, Zaina T. ;
Syed, Yahiya Y. ;
Scott, Lesley J. .
DRUGS, 2019, 79 (06) :665-674
[3]   Axitinib in the treatment of renal cell carcinoma: design, development, and place in therapy [J].
Bellesoeur, Audrey ;
Carton, Edith ;
Alexandre, Jerome ;
Goldwasser, Francois ;
Huillard, Olivier .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 :2801-2811
[4]   Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial [J].
Bruix, Jordi ;
Qin, Shukui ;
Merle, Philippe ;
Granito, Alessandro ;
Huang, Yi-Hsiang ;
Bodoky, Gyrogy ;
Pracht, Marc ;
Yokosuka, Osamu ;
Rosmorduc, Olivier ;
Breder, Valeriy ;
Gerolami, Rene ;
Masi, Gianluca ;
Ross, Paul J. ;
Song, Tianqiang ;
Bronowicki, Jean-Pierre ;
Ollivier-Hourmand, Isabelle ;
Kudo, Masatoshi ;
Cheng, Ann-Lii ;
Llovet, Josep M. ;
Finn, Richard S. ;
LeBerre, Marie-Aude ;
Baumhauer, Annette ;
Meinhardt, Gerold ;
Han, Guohong .
LANCET, 2017, 389 (10064) :56-66
[5]   The role of VEGF receptors in angiogenesis;: complex partnerships [J].
Cébe-Suarez, S ;
Zehnder-Fjällman, A ;
Ballmer-Hofer, K .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2006, 63 (05) :601-615
[6]   Mechanisms of receptor tyrosine kinase activation in cancer [J].
Du, Zhenfang ;
Lovly, Christine M. .
MOLECULAR CANCER, 2018, 17
[7]   Discovery of Antitubulin Agents with Antiangiogenic Activity as Single Entities with Multitarget Chemotherapy Potential [J].
Gangjee, Aleem ;
Pavana, Roheeth Kumar ;
Ihnat, Michael A. ;
Thorpe, Jessica E. ;
Disch, Bryan C. ;
Bastian, Anja ;
Bailey-Downs, Lora C. ;
Hamel, Ernest ;
Bai, Rouli .
ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (05) :480-484
[8]   Sorafenib for Advanced and Refractory Desmoid Tumors [J].
Gounder, Mrinal M. ;
Mahoney, Michelle R. ;
Van Tine, Brian A. ;
Ravi, Vinod ;
Attia, Steven ;
Deshpande, Hari A. ;
Gupta, Abha A. ;
Milhem, Mohammed M. ;
Conry, Robert M. ;
Movva, Sujana ;
Pishvaian, Michael J. ;
Riedel, Richard F. ;
Sabagh, Tarek ;
Tap, William D. ;
Horvat, Natally ;
Basch, Ethan ;
Schwartz, Lawrence H. ;
Maki, Robert G. ;
Agaram, Narasimhan P. ;
Lefkowitz, Robert A. ;
Mazaheri, Yousef ;
Yamashita, Rikiya ;
Wright, John J. ;
Dueck, Amylou C. ;
Schwartz, Gary K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (25) :2417-2428
[9]   Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals [J].
Gupta, Subash C. ;
Kim, Ji Hye ;
Prasad, Sahdeo ;
Aggarwal, Bharat B. .
CANCER AND METASTASIS REVIEWS, 2010, 29 (03) :405-434
[10]   The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future [J].
Hamming, Lisanne C. ;
Slotman, Ben J. ;
Verheul, Henk M. W. ;
Thijssen, Victor L. .
ANGIOGENESIS, 2017, 20 (02) :217-232
1234